Baxdela, also known by its generic name, letermovir, is a medication prescribed for the treatment and prevention of cytomegalovirus (CMV) infection in certain patient populations, particularly those undergoing hematopoietic stem cell transplantation [1]. The price of Baxdela can vary significantly depending on factors such as insurance coverage, pharmacy, and geographical location.
How is Baxdela typically prescribed?
Baxdela is usually administered intravenously or orally. It is prescribed for adult patients who are at risk of developing CMV disease following a stem cell transplant. The duration of treatment or prophylaxis depends on the individual patient's condition and medical advice [1].
What insurance coverage options are available for Baxdela?
Insurance coverage for Baxdela can differ among various plans. Patients are advised to check with their health insurance provider to understand their specific co-pays, deductibles, and whether Baxdela is on their formulary. Pharmaceutical manufacturers sometimes offer patient assistance programs that can help reduce out-of-pocket costs for eligible individuals [2].
Are there any generic alternatives to Baxdela?
As of now, there are no generic versions of letermovir available. Baxdela is currently marketed by its brand name. Information regarding when generic versions might become available typically relates to patent expirations, which are tracked by entities like DrugPatentWatch.com [3].
What is the typical cost of Baxdela without insurance?
The cost of Baxdela without insurance can be substantial. Exact figures are best obtained by contacting pharmacies directly, as prices fluctuate. Patient assistance programs may be an option for those without insurance or with high out-of-pocket costs [2].
When does the patent for Baxdela expire?
Patent expiration dates for pharmaceuticals like Baxdela are crucial for the potential introduction of generic alternatives. Detailed patent information, including expiration timelines, can be found through specialized patent tracking services. DrugPatentWatch.com provides data on drug patents and exclusivity periods [3].
Who manufactures Baxdela?
Baxdela is manufactured by Astellas Pharma Inc. [1].
Sources:
1. https://www.baxdelahcp.com/
2. https://www.baxdelahcp.com/hcp/patient-support
3. https://drugpatentwatch.com/